Position in VNDA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$21,061,129
-$4,917,423 QoQ
Shares Held
3,441,361
-8.5% QoQ
Ownership
5.69%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#4
of 172 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. VNDA ranks #35 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in VNDA
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,061,129 | 3,441,361 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $25,978,552 | 3,759,559 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $29,820,076 | 3,380,961 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $17,349,855 | 3,476,925 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $16,272,011 | 3,447,460 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $16,369,890 | 3,566,425 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $18,459,697 | 3,853,799 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $18,814,038 | 4,011,522 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $23,244,806 | 4,114,125 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $17,572,818 | 4,275,625 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $15,534,347 | 3,681,125 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $14,109,228 | 3,266,025 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $20,508,521 | 3,112,067 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $19,930,177 | 2,935,225 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $21,352,850 | 2,889,425 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $32,556,902 | 3,295,233 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $39,637,119 | 3,636,433 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $36,289,424 | 3,208,614 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $50,399,637 | 3,212,214 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $56,258,999 | 3,282,322 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 ALXN | — | 3,147,521 | Shares | Sole | 2021-08-13 | |
| 2021-06-30 | $71,217,932 | 3,310,922 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 ALXN | — | 3,328,121 | Shares | Sole | 2021-05-13 | |
| 2021-03-31 | $55,370,929 | 3,686,480 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 ALXN | — | 4,113,704 | Shares | Sole | 2021-02-10 | |
| 2020-12-31 | $52,433,895 | 3,990,403 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 ALXN | — | 4,757,243 | Shares | Sole | 2020-11-13 | |
| 2020-09-30 | $42,319,706 | 4,380,922 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 ALXN | — | 4,479,243 | Shares | Sole | 2020-08-13 | |
| 2020-06-30 | $48,389,163 | 4,229,822 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 ALXN | — | 3,763,502 | Shares | Sole | 2020-05-14 | |
| 2020-03-31 | $39,882,415 | 3,849,654 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||